InMed Pharmaceuticals EV 2011-2026 | INM

EV Jährlich InMed Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-5.18 M	555 K	-4.69 M	43.5 M	1.56 M	938 K	370 K	590 K	77.6 K	74.8 K	51.8 K	45.4 K	44.8 K

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
43.5 M	-5.18 M	2.92 M

EV anderer Aktien in der Pharmaeinzelhändler

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
AbbVie ABBV	394 B	$ 209.63	-0.71 %	$ 371 B	USA
Verastem VSTM	388 M	$ 4.99	-5.77 %	$ 346 M	USA
VistaGen Therapeutics VTGN	20.3 M	$ 0.57	-5.85 %	$ 17.6 M	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Voyager Therapeutics VYGR	232 M	$ 3.96	-4.24 %	$ 232 M	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Aileron Therapeutics ALRN	4.02 M	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	5.65 B	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	270 M	-	-	$ 546 M	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Avid Bioservices CDMO	661 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	2.7 B	$ 12.36	-11.46 %	$ 1.88 B	USA
Wave Life Sciences Ltd. WVE	2.11 B	$ 6.39	3.06 %	$ 1.08 B	Singapore
Xenetic Biosciences XBIO	-2.54 M	$ 2.78	-0.71 %	$ 4.73 M	USA
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
XBiotech XBIT	-45.4 M	$ 2.27	-1.73 %	$ 69.2 M	USA
Xenon Pharmaceuticals XENE	2.9 B	$ 54.44	-1.96 %	$ 4.24 B	Canada
Xeris Pharmaceuticals XERS	1.23 B	$ 5.41	-2.87 %	$ 868 M	USA
X4 Pharmaceuticals XFOR	66 M	$ 4.07	-5.57 %	$ 172 M	USA
Xencor XNCR	1.08 B	$ 11.4	-7.43 %	$ 846 M	USA
XOMA Corporation XOMA	416 M	$ 29.93	-1.97 %	$ 362 M	USA
22nd Century Group XXII	1.92 M	$ 2.41	-18.03 %	$ 444 K	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	71.1 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	91.4 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	122 M	$ 1.06	-2.75 %	$ 21.7 M	Israel
Enochian Biosciences ENOB	145 M	-	-	$ 40.5 M	USA